These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6765080)

  • 21. [Isolation frequency and spectrum of sensitivity to antifungal preparations of vulvovaginal candidiasis pathogens].
    Skliar TV; Krysenko AV; Sirokvasha EA; Vinnikov AI
    Mikrobiol Z; 2007; 69(3):57-62. PubMed ID: 17682532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method.
    Ostrosky-Zeichner L; Rex JH; Pfaller MA; Diekema DJ; Alexander BD; Andes D; Brown SD; Chaturvedi V; Ghannoum MA; Knapp CC; Sheehan DJ; Walsh TJ
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4175-7. PubMed ID: 18809944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microbial profile and drug resistance of Candida strains isolated from the blood of children: an 11-year study.
    Małafiej E; Adamiec AC; Tworzyańska U
    Mycoses; 2009 Mar; 52(2):149-53. PubMed ID: 18627468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
    Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
    J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
    Jandourek A; Brown P; Vazquez JA
    Clin Infect Dis; 1999 Dec; 29(6):1583-4. PubMed ID: 10585825
    [No Abstract]   [Full Text] [Related]  

  • 26. Isolation, characterization and antifungal susceptibility pattern of Candida species causing oropharyngeal candidiasis in HIV positive patients.
    Maninder J; Usha A
    J Commun Dis; 2008 Sep; 40(3):177-81. PubMed ID: 19245155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The epidemiology of Candida infections in Göttingen and Germany].
    Borg-von Zepelin M
    Mycoses; 2008 Sep; 51 Suppl 3():17-9. PubMed ID: 18782238
    [No Abstract]   [Full Text] [Related]  

  • 28. Does one voriconazole breakpoint suit all Candida species?
    Arendrup MC; Denning DW; Pfaller MA; Diekema DJ; Rex JH
    J Clin Microbiol; 2007 Jun; 45(6):2093; author reply 2094. PubMed ID: 17548458
    [No Abstract]   [Full Text] [Related]  

  • 29. Rapid identification of fluconazole resistance using Chromagar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; John ES
    Indian J Pathol Microbiol; 2000 Jul; 43(3):343-6. PubMed ID: 11218683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential risk factors for infection with Candida spp. in critically ill patients.
    Peres-Bota D; Rodriguez-Villalobos H; Dimopoulos G; Melot C; Vincent JL
    Clin Microbiol Infect; 2004 Jun; 10(6):550-5. PubMed ID: 15191384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
    Muñoz P; Sánchez-Somolinos M; Alcalá L; Rodríguez-Créixems M; Peláez T; Bouza E
    J Antimicrob Chemother; 2005 Feb; 55(2):188-93. PubMed ID: 15650001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics of vulvovaginal candidiasis and antifungal susceptibilities of Candida species isolates among patients in southern China from 2003 to 2006.
    Fan SR; Liu XP; Li JW
    J Obstet Gynaecol Res; 2008 Aug; 34(4):561-6. PubMed ID: 18937710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients.
    Marol S; Yücesoy M
    Mycoses; 2008 Jan; 51(1):40-9. PubMed ID: 18076594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity of clotrimazole for Candida strains isolated from recent patient samples.
    Schmidt A
    Arzneimittelforschung; 1995 Dec; 45(12):1338-40. PubMed ID: 8595097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid identification of fluconazole resistance using Chrom agar Candida.
    Verghese SL; Padmaja P; Sutha P; Mathew T; Johni ES
    Indian J Pathol Microbiol; 2001 Jul; 44(3):305-7. PubMed ID: 12024918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antifungal susceptibility of clinical Candida parapsilosis isolates in Kuwait.
    Asadzadeh M; Al-Sweih NA; Ahmad S; Khan ZU
    Mycoses; 2008 Jul; 51(4):318-23. PubMed ID: 18855844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Candida auris in Germany and Previous Exposure to Foreign Healthcare.
    Hamprecht A; Barber AE; Mellinghoff SC; Thelen P; Walther G; Yu Y; Neurgaonkar P; Dandekar T; Cornely OA; Martin R; Kurzai O;
    Emerg Infect Dis; 2019 Sep; 25(9):1763-1765. PubMed ID: 31223105
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival of the Fittest, Part 2: The Emergence of Super Fungi.
    Salcido RS
    Adv Skin Wound Care; 2017 Oct; 30(10):437. PubMed ID: 28914677
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.